echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Xuzhou City, Jiangsu Province requires all pharmacies with lock-in points to sell centralized medicines

    Xuzhou City, Jiangsu Province requires all pharmacies with lock-in points to sell centralized medicines

    • Last Update: 2023-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The collection of drugs into pharmacies has become an unstoppable trend
    .
    01Establish all pharmacies with lock-in points into "medical insurance convenience pharmacies" According to China's Jiangsu Net, since the beginning of this year, Jiangsu Xuzhou Medical Insurance Bureau has carried out the construction of "medical insurance convenience pharmacy" throughout the city, and at present, 161 designated retail pharmacies of medical insurance in the city have passed the acceptance inspection and officially listed as "medical insurance convenience pharmacies", achieving basic coverage
    of the townships (streets) where the "15-minute medical insurance service circle" is located 。 At present, Xuzhou has built 161 medical insurance convenience pharmacies covering 150 townships (streets) in the city, including 48 in Xuzhou City, 15 in Feng County, 17 in Pei County, 10 in Suining County, 25 in Pizhou City, 18 in Xinyi City, 16 in Tongshan District and 12 in Jiawan District, mainly including 138 chain retail pharmacies and 23 single retail pharmacies
    .
    The drugs sold cover 190 kinds of medical insurance centralized procurement drugs and 275 kinds of national negotiation drugs, all of which are sold
    according to the "zero difference rate" between the centralized procurement price and the national negotiation price 。 In May this year, the Jiangsu Medical Insurance Bureau proposed the construction of "convenient medical insurance pharmacies", requiring the selection of grassroots designated retail pharmacies with better hardware conditions, standardized management safety and high-quality services in townships (streets) as medical insurance convenience pharmacies, and promoting medical insurance convenience pharmacies to provide grassroots people with national and provincial centralized procurement of drugs and state-negotiated drugs by allowing medical insurance convenience pharmacies to participate in national and provincial drug centralized procurement and signing special medical insurance agreements, and implementing "zero price difference" sales
    .
    Jiangsu medical insurance department stated that within this year, medical insurance convenience pharmacies will first be fully covered
    in the "15-minute service circle demonstration point" in provinces and cities.
    It is worth noting that in the planning of the Xuzhou Medical Insurance Bureau, by the end of March 2023, all the city's lock-point stores will be built as "medical insurance convenience pharmacies", and new lock-point stores must be built as "medical insurance convenience pharmacies"
    at the same time.
    For designated stores that still do not meet the construction standards of "medical insurance convenience pharmacies" after expiration, they will be included in the key supervision targets of medical insurance in the year, increase the frequency of supervision and inspection, focus on the inspection of drug purchase, sales and inventory and procurement channels, and at the same time no longer accept applications from designated retail pharmacies with stores under the chain headquarters
    .
    02Centralized procurement of drugs into pharmacies to speed up expansion With the normalization, institutionalization and "acceleration and expansion" of drug procurement, the scope of participation targets has also been continuously "expanded", including more pharmacies
    .
    In November 2018, drug centralized procurement began to be piloted in 11 cities across the country, and so far 7 batches of national drug centralized procurement have been carried out, with an average reduction of more than 50%
    in drug prices.
    The statistical results show that the first six batches of drug centralized procurement covered a total of 234 varieties, involving 237 billion yuan, accounting for 30%
    of the total chemical procurement amount of public medical institutions.
    As of the end of February 2022, a total of 44 batches of provincial-level drug centralized procurement have been carried out in various places, of which 28 batches have been carried out independently at the provincial level and 16 batches have been purchased by provincial alliances, with an average of 5 batches of drugs in each province and an average of 50 drugs
    per province.
    According to the relevant person in charge of the National Medical Insurance Administration, by the end of this year, through the procurement of national organizations and provincial alliances, each province will cover an average of more than 350 varieties
    。 At the same time as the "expansion" of centralized procurement of drugs, the pharmacies included in the centralized procurement are also "expanding": in May 2019, Shandong issued a notice to include chain pharmacies in the centralized procurement system from July 1; In June 2019, Shanghai issued the "Work Tips on "Restricted Pharmacy Drug Full Online Public Negotiation" and Other Related Matters, requiring designated pharmacies to "fully implement online public bargaining procurement of drugs"; In December 2021, Henan included more than 9,000 designated retail pharmacies in the scope of centralized procurement.
    .
    .
    Although the gross profit margin of centralized procurement varieties is low, it brings new traffic growth opportunities
    to stores.
    Relevant data show that in the week of opening, the sales amount of pharmacies in Zibo increased by more than 40% on average, with the highest growth rate of 62.
    8%; The number of drugs sold increased by an average of 46%, with a maximum increase of 80%, and patient traffic increased by more than
    20% on average.
    While bringing customer flow, the collected varieties also provide opportunities
    for pharmacies to harvest the dividends of chronic diseases.
    From the perspective of business categories, the current centralized procurement varieties sold by pharmacies involve dozens of urgently needed drugs such as hypertension and diabetes, and pharmacies participating in centralized procurement are expected to drive the growth of related categories with increased customer flow, enhance the viscosity of consumers with professional services, and further build community health service centers
    .
    03Pharmacies take the initiative to embrace the tide of centralized procurement In fact, more and more pharmacies are actively embracing the tide of centralized procurement, and for pharmacies, the sale of centralized procurement drugs is more for the consideration
    of transformation and upgrading.
    Whether it is the "medical insurance convenience pharmacy" promoted by Jiangsu or the "centralized procurement of medicine cabinets into pharmacies" piloted in Shanxi, this kind of form of building a platform by the government to promote docking solves the problem that pharmacies cannot enjoy the centralized procurement price of hospitals when purchasing goods, reduces the threshold for pharmacies to obtain low-priced, high-quality varieties, and saves procurement costs
    。 As drug centralized procurement enters the normalization, many pharmaceutical companies have shifted their attention to the out-of-hospital market, which also means that more resources will be tilted to retail channels, and pharmacies are expected to obtain more resources and professional empowerment provided by pharmaceutical companies to achieve their own transformation and upgrading
    .
    In addition, documents such as "dual-channel" management and long-term prescription mechanism have been issued one after another, affirming the characteristics of wide coverage, high marketization and flexible services of designated retail pharmacies, and emphasizing the functional positioning
    of "complementing each other with designated medical institutions to form a joint force of supply security".
    Community pharmacies cover centralized procurement of drugs, which means that "standardized management of chronic diseases" can be better realized
    at home and in the community.
    In this regard, Xu Wei, a professor at the International Medical Business School of China Pharmaceutical University, believes at the 2022 MISI Conference that in recent years, new policies such as centralized procurement and national drug "dual channels" have been frequently introduced, which have a far-reaching impact
    on the development of the pharmaceutical retail market 。 For the impact of the pharmaceutical retail market, he said that under the normalization of centralized procurement, the domestic substitution effect of drugs is obvious, and products with brand influence have begun to turn to the retail market, increasing supply opportunities to the market, at the same time, this has also changed the marketing model and product structure of pharmacies, increasing the proportion of traditional Chinese medicine and other characteristic products with higher gross profit, and is expected to maintain stable
    profit margins 。 With the landing of the "dual channel" of national drugs, the market share of pharmacies will increase significantly, in addition, the increase of designated pharmacy channels, giving full play to its wide distribution, high degree of marketization, flexible services and other advantages, can ensure the accessibility of patients' medication and reduce the economic burden
    of patients.
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.